Biotech News
Phathom Pharmaceuticals to Present at the Guggenheim Emerging Outlook Biotech Summit 2026
investors.phathompharma.com2026-05-06 14:57 EST
FLORHAM PARK, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that members of its management team will participate in a